These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Novel directions in inflammation as a therapeutic target in atherosclerosis. Verweij SL; van der Valk FM; Stroes ES Curr Opin Lipidol; 2015 Dec; 26(6):580-5. PubMed ID: 26382552 [TBL] [Abstract][Full Text] [Related]
6. Targeting inflammation in cardiovascular diseases. still a neglected field? Gómez-Guerrero C; Mallavia B; Egido J Cardiovasc Ther; 2012 Aug; 30(4):e189-97. PubMed ID: 21884009 [TBL] [Abstract][Full Text] [Related]
7. Inflammation in atherosclerosis and psoriasis: common pathogenic mechanisms and the potential for an integrated treatment approach. Späh F Br J Dermatol; 2008 Aug; 159 Suppl 2():10-7. PubMed ID: 18700910 [TBL] [Abstract][Full Text] [Related]
8. Development of anti-atherosclerosis therapy based on the inflammatory and proliferative aspects of the disease. Maranhão RC; Leite AC Curr Pharm Des; 2015; 21(9):1196-204. PubMed ID: 25312729 [TBL] [Abstract][Full Text] [Related]
9. Inflammation and beyond: new directions and emerging drugs for treating atherosclerosis. Bertrand MJ; Tardif JC Expert Opin Emerg Drugs; 2017 Mar; 22(1):1-26. PubMed ID: 27927063 [TBL] [Abstract][Full Text] [Related]
10. Potential of anti-inflammatory agents for treatment of atherosclerosis. Chistiakov DA; Melnichenko AA; Grechko AV; Myasoedova VA; Orekhov AN Exp Mol Pathol; 2018 Apr; 104(2):114-124. PubMed ID: 29378168 [TBL] [Abstract][Full Text] [Related]
11. Novel anti-inflammatory therapies for the treatment of atherosclerosis. Khan R; Spagnoli V; Tardif JC; L'Allier PL Atherosclerosis; 2015 Jun; 240(2):497-509. PubMed ID: 25917947 [TBL] [Abstract][Full Text] [Related]
12. Effect of interleukin 1β inhibition in cardiovascular disease. Qamar A; Rader DJ Curr Opin Lipidol; 2012 Dec; 23(6):548-53. PubMed ID: 23069985 [TBL] [Abstract][Full Text] [Related]
13. Clinical value of drugs targeting inflammation for the management of coronary artery disease. Duchatelle V; Kritikou EA; Tardif JC Can J Cardiol; 2012; 28(6):678-86. PubMed ID: 22926034 [TBL] [Abstract][Full Text] [Related]
14. Statins and other agents for vascular inflammation. Owens CD J Vasc Surg; 2012 Dec; 56(6):1799-806. PubMed ID: 23017371 [TBL] [Abstract][Full Text] [Related]
15. [Atherosclerosis and arteriitis: implications for therapy of cardiovascular disease]. Galle J Herz; 2004 Feb; 29(1):4-11. PubMed ID: 14968336 [TBL] [Abstract][Full Text] [Related]
16. Effect of antiplatelet therapy on inflammatory markers in atherothrombotic patients. Muhlestein JB Thromb Haemost; 2010 Jan; 103(1):71-82. PubMed ID: 20062914 [TBL] [Abstract][Full Text] [Related]
17. Anti-atherogenic properties of fibrates may be largely due to their anti-inflammatory effects. Ye HJ; Zhao SP Med Hypotheses; 2006; 66(3):495-500. PubMed ID: 16289368 [TBL] [Abstract][Full Text] [Related]
18. Cardiovascular risk factors in inflammatory arthritis. Mirjafari H; Al-Husain A; Bruce IN Curr Opin Lipidol; 2011 Aug; 22(4):296-301. PubMed ID: 21670670 [TBL] [Abstract][Full Text] [Related]
19. Cellular and cytokine-based inflammatory processes as novel therapeutic targets for the prevention and treatment of atherosclerosis. Little PJ; Chait A; Bobik A Pharmacol Ther; 2011 Sep; 131(3):255-68. PubMed ID: 21510977 [TBL] [Abstract][Full Text] [Related]